These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5068195)

  • 1. [Treatment of liver cirrhoses with xantinole nicotinate. Results of a double blind study].
    Schnack H
    Munch Med Wochenschr; 1972 Mar; 114(10):460-2. PubMed ID: 5068195
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of zinc deficiency on effectiveness of the treatment of liver encephalopathy in patients with liver cirrhoses].
    Shaposhnikova NA; Drozdov VN; Petrakov AV; Sil'vestrova SIu
    Eksp Klin Gastroenterol; 2007; (5):46-50, 164. PubMed ID: 18389597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of liver cirrhosis. Studies on the hemodynamic effect of xanthinol nicotinate in liver cirrhosis].
    Assheuer J; Boldt I; Schulz D; Winkler C
    Fortschr Med; 1973 Sep; 91(27):1085-8. PubMed ID: 4746762
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypokalemia, potassium loss and liver cirrhosis. Value of potassium chloride sustained-release tablets].
    Lévy VG; Caroli J
    Therapeutique; 1971 Dec; 47(10):845-51. PubMed ID: 5145546
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical studies on the effectiveness of Xantinol-nicotinate in chronic hepatitis and liver cirrhosis].
    Dohrmann RE; Konrad D; Sawade H; Kühl I
    Med Klin; 1968 Nov; 63(44):1772-6. PubMed ID: 5704508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydralazine in arterial hypertension. Randomized, double-blind comparison between conventional and slow-release preparations].
    Wulff K; Lenz K; Krogsgaard AR; Holst B
    Ugeskr Laeger; 1980 Jul; 142(29):1862-5. PubMed ID: 6996259
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiinflammatory and antifibrogenic activities of colchicine: treatment of liver cirrhosis.
    Rojkind M; Mourelle M; Kershenobich D
    Prog Clin Biol Res; 1984; 154():475-89. PubMed ID: 6382308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with depot form flupenthixol].
    Bruck J; Guss H
    Wien Med Wochenschr; 1971 Feb; 121(7):110-2. PubMed ID: 5545657
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative double-blind, randomized, crossover study controlled with placebo, of the efficacy of depot nifedipine in patients refractory to basic antihypertensive therapy].
    Bozza AE; Guimarães FJ; de Carvalho FJ; Santos LC; Pellon FM; de Castro RF; Balbuena RR
    Arq Bras Cardiol; 1984 Sep; 43(3):213-7. PubMed ID: 6398994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative double-blind, crossover and randomized study of the antihypertensive activity of nifedipine in primary arterial hypertension].
    de Mendonça JV; de Castro Filho J
    Arq Bras Cardiol; 1984 Sep; 43(3):219-22. PubMed ID: 6398995
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I; Feu F; Luca A; García-Pagán JC; Fernández M; Escorsell A; Bosch J; Rodés J
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Double-blind comparative study of slow-release ketoprofen and a placebo in chronic inflammatory rheumatism].
    Harrewyn JM; Amor B
    Sem Hop; 1983 Dec; 59(46):3225-8. PubMed ID: 6318347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients].
    Grigor'iants RA; Lupanov VP; Samoĭlenko LE; Lobova NM
    Ter Arkh; 1984; 56(4):67-70. PubMed ID: 6427964
    [No Abstract]   [Full Text] [Related]  

  • 17. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L; Giostra E; Frossard JL; Morard I; Mentha G; Hadengue A
    Am J Gastroenterol; 2007 Jul; 102(7):1397-405. PubMed ID: 17488248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of decompensated liver cirrhosis with corpus luteum hormone].
    László B
    Wien Z Inn Med; 1967; 48(11):442-4. PubMed ID: 5620583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Delayed-action clomipramine tablets in 78 ambulatory depressive patients: a double-blind study].
    Boom AJ; Hevest HP; Krypsin-Exner K; van der Poel FW
    Ther Umsch; 1983 Sep; 40(9):805-9. PubMed ID: 6356449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hormonal treatment of liver cirrhosis].
    Vazquez HR
    Prensa Med Argent; 1971 Dec; 58(40):1959-61. PubMed ID: 5137764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.